SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
San Diego-based Cadence Pharmaceuticals Inc. is being acquired by Irish specialty drugmaker Mallinckrodt PLC for $1.3 billion.
Imprimis Pharmaceuticals Inc. has agreed to buy Pharmacy Creations LLC for a base price of $600,000 dollars.
Mast Therapeutics Inc. has agreed to acquire Aires Pharmaceuticals Inc. at a steep discount, in an all-stock deal worth about $5.2 million.
Pasadena-based Alexandria Real Estate Equities Inc. has purchased a Torrey Pines office and industrial building for $64 million, according to CoStar Group and public data.
Ligand Pharmaceuticals Inc. announced that it has earned $1 million commercial milestone payment from Onyx Pharmaceuticals.
The Biocom Institute announced that Kristie Grover has resigned as executive director, effective Feb. 28.
Emergency medical service provider Falck San Diego will give rides to senior citizens and others who need special medical assistance to get to their polling locations for San Diego’s special mayoral election.
HEALTH: Interim CEO Talks Candidly of Plans, Challenges
The woman had extreme stomach pains and was on the verge of passing out. Tri-City Medical Center was a stone’s throw away, but she adamantly refused to go there because she’d heard its care was substandard — opting instead for the far-away Scripps Encinitas hospital. When the woman fainted, however, her husband took her to Tri-City, where the physicians there saved her life.
HEALTH: Covered California’s Big Names Get Most Enrollees
More than 45,000 San Diegans signed up for health insurance via Covered California through the end of December. The vast majority of them qualified for income-based subsidies and chose plans with good brand recognition and a history of providing insurance to individuals.
Biotech billionaire Patrick Soon-Shiong has a modest proposal: cure cancer, eradicate influenza and maybe save the world. I’m reminded of Tony Stark, if the Marvel superhero were a 61-year-old, bespectacled man with a graceful South African lilt.
Biocept Inc. began trading on the Nasdaq on Feb. 5, raising $19 million.
La Jolla-based Auspex Pharmaceuticals Inc. announced the pricing of its $82.8 million initial public offering — just a month after it raised $35 million in venture funding.
San Diego-based aTyr Pharma named Frederic Chereau president and chief operating officer.
Second-quarter profit for San Diego medical device maker CareFusion Corp. dropped 10 percent despite higher-than-expected revenue growth, due in part to the company’s heavy expenses in the quarter.
Leading BioSciences Inc., a San Diego biotech developing treatments for multiple organ failure, has appointed Robin M. Jackman as its new chief executive.